PEOPLE - Changes at Vivacta:
This article was originally published in Clinica
In vitro diagnostics firm Vivacta has appointed Rolf Classon as chairman and Werner Schafer as non-executive director. Mr Classon joins the Kent, UK firm from Bayer Healthcare, where he was chairman of the executive committee. Dr Schafer joins Vivacta from Lab Systems Business Unit, Roche, where he was president.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.